Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Cervical cancer: does the western world have a benefit?

Gemma Kenter, MD, PhD, of the Amsterdam Centre for Oncological Gynaecology, Amsterdam, The Netherlands, tells us about a trial she was involved with that investigated the use of neoadjuvant chemotherapy and radical surgery to standard chemotherapy and radiation for the treatment of cervical cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.